Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.3K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

943
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
943
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

314
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
314
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

209
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
209
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

263
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk estimation and dynamic prediction using discrete-time joint models for longitudinal and multistate data with interval and state censoring.

Biostatistics (Oxford, England)·2026
Same author

On the differential hemodynamic effects of prostacyclins and sotatercept.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Child and mother study satisfaction in a longitudinal study of children at-risk for type 1 diabetes.

BMC pediatrics·2026
Same author

Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Cracks in the Estrogen Carcinogenesis of Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Jan 19, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.3K

Reply: Strategies to Prevent Cardiotoxicity

Maya Guglin, Roy Tamura, Jeffrey Krischer

    Journal of the American College of Cardiology
    |September 28, 2019
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
    08:09

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

    Published on: June 7, 2018

    10.3K
    Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
    04:53

    Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

    Published on: August 25, 2022

    2.1K

    Related Experiment Videos

    Last Updated: Jan 19, 2026

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.3K
    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
    08:09

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

    Published on: June 7, 2018

    10.3K
    Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
    04:53

    Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

    Published on: August 25, 2022

    2.1K